首页> 外文期刊>The journal of trauma and acute care surgery >Acute lethal crush-injured rats can be successfully rescued by a single injection of high-dose dexamethasone through a pathway involving PI3K-Akt-eNOS signaling
【24h】

Acute lethal crush-injured rats can be successfully rescued by a single injection of high-dose dexamethasone through a pathway involving PI3K-Akt-eNOS signaling

机译:可以通过涉及PI3K-Akt-eNOS信号传导的途径单次注射大剂量地塞米松来成功挽救急性致死性挤压伤的大鼠

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: Crush syndrome (CS) is characterized by ischemia/reperfusion- induced rhabdomyolysis and the subsequent onset of systemic inflammation. CS is associated with a high mortality, even when patients are treated with conventional therapy. We hypothesized that treatment of lethal CS rat model with dexamethasone (DEX) have therapeutic effects on the laboratory findings and clinical course and outcome. METHODS: To create a CS model, anesthetized rats were subjected to bilateral hind limb compression with rubber tourniquets for 5 hours and randomly divided into three groups as follows: saline-treated CS group, CS groups treated with low (0.1 mg/kg) and high doses (5.0 mg/kg) of DEX. Saline for the CS group or DEX for the DEX-treated CS groups was intravenously administered immediately before reperfusion. Under continuous monitoring and recording of arterial blood pressures, blood and tissue samples were collected for histologic and biochemical analysis at designated period before and after reperfusion. RESULTS: Ischemic compression of rat hind limbs reduced the nitrite content in the crushed muscle, and the subsequent reperfusion induced reactive oxygen species-mediated circulatory collapse and systemic inflammation, finally resulting in a mortality rate of 76% by 48 hours after reperfusion. A single injection of high-dose DEX immediately before reperfusion activated endothelial nitric oxide synthase (eNOS) by sequential phosphorylation through the nongenomic phosphoinositide 3-kinase (PI3K)-Akt-eNOS signaling pathway. DEX also exhibited anti-inflammatory effects by modulating proinflammatory and anti-inflammatory mediators, consequently suppressing myeloperoxidase activities and subsequent systemic inflammation, showing a complete recovery of the rats from lethal CS. CONCLUSION: These results indicate that high-dose DEX reduces systemic inflammation and contributes to the improved survival rate in a rat CS model.
机译:背景:挤压综合征(CS)的特征是缺血/再灌注引起的横纹肌溶解和随后的全身性炎症发作。即使患者接受常规治疗,CS的死亡率也很高。我们假设地塞米松(DEX)治疗致死CS大鼠模型对实验室检查结果,临床过程和结果具有治疗作用。方法:为建立CS模型,将麻醉的大鼠用橡胶止血带进行双侧后肢加压5小时,并随机分为三组:盐水治疗的CS组,低剂量的CS组(0.1 mg / kg)和生理盐水治疗的CS组。高剂量(5.0 mg / kg)的DEX。在再灌注之前,立即静脉注射CS组的盐水或DEX治疗的CS组的DEX。在连续监测和记录动脉血压的情况下,在再灌注之前和之后的指定时间段收集血液和组织样本以进行组织学和生化分析。结果:大鼠后肢的缺血性压迫降低了压迫肌肉中亚硝酸盐的含量,随后的再灌注引起活性氧介导的循环衰竭和全身性炎症,最终导致再灌注后48小时的死亡率达到76%。再灌注前单次注射大剂量DEX会通过非基因组磷酸肌醇3激酶(PI3K)-Akt-eNOS信号传导途径将其顺序磷酸化,从而激活内皮一氧化氮合酶(eNOS)。 DEX还通过调节促炎和抗炎介质发挥抗炎作用,因此抑制了髓过氧化物酶活性和随后的全身性炎症,表明大鼠从致死性CS中完全康复。结论:这些结果表明高剂量的DEX可以减轻全身炎症反应,并有助于提高大鼠CS模型的存活率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号